Histologische und hämatologische Befunde bei der CML View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-01

AUTHORS

J. Thiele, H. M. Kvasnicka, A. Schmitt-Graeff, H. E. Schaefer

ABSTRACT

An immunohistochemical and morphometric study was performed on bone marrow biopsies in 604 patients with chronic myelogenous leukemia (CML) to compare morphological and clinical features and to evaluate effects of interferon (IFN) and chemotherapy. Following morphometry significant correlations were calculated between number of CD61+ megakaryocytes, including their precursors with fiber density. This finding is in line with the close functional relationship between megakaryopoiesis and fibroblasts regarding the complex pathomechanism of myelofibrosis. The latter was observed in about 28% of patients already at diagnosis. In a similar way, the frequency of CD68+ macrophages was correlated with the amount of Ret40f+ nucleated erythroid precursors, implicating an involvement of this cell lineage in iron turnover, hemoglobin synthesis, and degradation of the expelled nuclei from normoblasts. The (α-D-galactosyl residue-expressing) Pseudo-Gaucher cells were detectable in 30% of pretreatment specimens. Moreover, significant associations were calculable between reduction in erythropoiesis or increase in fibers with clinical features such as hemoglobin level, percentages of myelo- and erythroblasts in the peripheral blood, and spleen size. These variables are in keeping with more advanced stages of CML. Based on our morphometric evaluations, a classification into three different histological subgroups: granulocytic, megakaryocytic, and myelofibrotic was carried out. This simplified staging system was correlated with corresponding sets of hematological data. Sequential biopsies in 173 patients with monotherapy by IFN, hydroxyurea (HU), or busulfan (BU) revealed a fibrogenic effect of IFN in contrast to a fiber-reducing property of HU. The dynamics of myelofibrosis and changes of major cell lineages during treatment were readily demonstrable by calculating corresponding indices. These included the ratios between quantitative differences of corresponding variables at repeated examinations and time. Thus, in patients with complete hematological remission following IFN administration, regeneration of erythropoiesis was found to be accompanied by an increase in the total number of CD68+ macrophages, including activated subpopulations. Histological subgroups showed a transition from a (nonfibrotic) granulocytic and megakaryocyte pattern to the myelofibrotic subtype in about 40% of patients. This change was opposed to a numerical reduction in the myelofibrotic subtype which occurred in 17 patients (36%), but predominantly in those under HU therapy. In conclusion, the striking heterogeneity of bone marrow features in CML warrants a careful morphological evaluation of trephine biopsies and appropriate means of processing to achieve relevant correlations with clinical data and, thus, allows a more elaborate insight into the dynamics of the disease process. More... »

PAGES

39-54

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002920050005

DOI

http://dx.doi.org/10.1007/s002920050005

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1004984507

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10663668


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Cell Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Erythropoiesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macrophages", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reference Values", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Zentrum f\u00fcr Pathologie der Universit\u00e4t zu K\u00f6ln, DE", 
          "id": "http://www.grid.ac/institutes/grid.6190.e", 
          "name": [
            "Zentrum f\u00fcr Pathologie der Universit\u00e4t zu K\u00f6ln, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thiele", 
        "givenName": "J.", 
        "id": "sg:person.01160664600.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160664600.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Zentrum f\u00fcr Pathologie der Universit\u00e4t zu K\u00f6ln, DE", 
          "id": "http://www.grid.ac/institutes/grid.6190.e", 
          "name": [
            "Zentrum f\u00fcr Pathologie der Universit\u00e4t zu K\u00f6ln, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kvasnicka", 
        "givenName": "H. M.", 
        "id": "sg:person.012401210064.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012401210064.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pathologisches Institut der Albert-Ludwigs-Universit\u00e4t Freiburg, DE", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Pathologisches Institut der Albert-Ludwigs-Universit\u00e4t Freiburg, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schmitt-Graeff", 
        "givenName": "A.", 
        "id": "sg:person.0657700770.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657700770.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pathologisches Institut der Albert-Ludwigs-Universit\u00e4t Freiburg, DE", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Pathologisches Institut der Albert-Ludwigs-Universit\u00e4t Freiburg, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schaefer", 
        "givenName": "H. E.", 
        "id": "sg:person.01116304300.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116304300.49"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2000-01", 
    "datePublishedReg": "2000-01-01", 
    "description": "An immunohistochemical and morphometric study was performed on bone marrow biopsies in 604 patients with chronic myelogenous leukemia (CML) to compare morphological and clinical features and to evaluate effects of interferon (IFN) and chemotherapy. Following morphometry significant correlations were calculated between number of CD61+ megakaryocytes, including their precursors with fiber density. This finding is in line with the close functional relationship between megakaryopoiesis and fibroblasts regarding the complex pathomechanism of myelofibrosis. The latter was observed in about 28% of patients already at diagnosis. In a similar way, the frequency of CD68+ macrophages was correlated with the amount of Ret40f+ nucleated erythroid precursors, implicating an involvement of this cell lineage in iron turnover, hemoglobin synthesis, and degradation of the expelled nuclei from normoblasts. The (\u03b1-D-galactosyl residue-expressing) Pseudo-Gaucher cells were detectable in 30% of pretreatment specimens. Moreover, significant associations were calculable between reduction in erythropoiesis or increase in fibers with clinical features such as hemoglobin level, percentages of myelo- and erythroblasts in the peripheral blood, and spleen size. These variables are in keeping with more advanced stages of CML. Based on our morphometric evaluations, a classification into three different histological subgroups: granulocytic, megakaryocytic, and myelofibrotic was carried out. This simplified staging system was correlated with corresponding sets of hematological data. Sequential biopsies in 173 patients with monotherapy by IFN, hydroxyurea (HU), or busulfan (BU) revealed a fibrogenic effect of IFN in contrast to a fiber-reducing property of HU. The dynamics of myelofibrosis and changes of major cell lineages during treatment were readily demonstrable by calculating corresponding indices. These included the ratios between quantitative differences of corresponding variables at repeated examinations and time. Thus, in patients with complete hematological remission following IFN administration, regeneration of erythropoiesis was found to be accompanied by an increase in the total number of CD68+ macrophages, including activated subpopulations. Histological subgroups showed a transition from a (nonfibrotic) granulocytic and megakaryocyte pattern to the myelofibrotic subtype in about 40% of patients. This change was opposed to a numerical reduction in the myelofibrotic subtype which occurred in 17 patients (36%), but predominantly in those under HU therapy. In conclusion, the striking heterogeneity of bone marrow features in CML warrants a careful morphological evaluation of trephine biopsies and appropriate means of processing to achieve relevant correlations with clinical data and, thus, allows a more elaborate insight into the dynamics of the disease process.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002920050005", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1446220", 
        "issn": [
          "2731-7188", 
          "2731-7196"
        ], 
        "name": "Die Pathologie", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "chronic myelogenous leukemia", 
      "clinical features", 
      "histological subgroups", 
      "number of CD61", 
      "frequency of CD68", 
      "complete hematological remission", 
      "bone marrow features", 
      "bone marrow biopsy", 
      "pseudo-Gaucher cells", 
      "nucleated erythroid precursors", 
      "careful morphological evaluation", 
      "effect of interferon", 
      "different histological subgroups", 
      "dynamics of myelofibrosis", 
      "IFN administration", 
      "marrow features", 
      "hematological remission", 
      "complex pathomechanism", 
      "hemoglobin levels", 
      "marrow biopsy", 
      "peripheral blood", 
      "staging system", 
      "HU therapy", 
      "pretreatment specimens", 
      "trephine biopsy", 
      "spleen size", 
      "sequential biopsies", 
      "clinical data", 
      "fibrogenic effects", 
      "myelogenous leukemia", 
      "cell lineages", 
      "patients", 
      "disease process", 
      "advanced stage", 
      "hematological data", 
      "significant association", 
      "interferon", 
      "iron turnover", 
      "morphometric evaluation", 
      "biopsy", 
      "regeneration of erythropoiesis", 
      "fiber density", 
      "erythroid precursors", 
      "morphometric study", 
      "close functional relationship", 
      "CD68", 
      "busulfan", 
      "significant correlation", 
      "morphological evaluation", 
      "myelofibrosis", 
      "hemoglobin synthesis", 
      "numerical reduction", 
      "major cell lineages", 
      "subtypes", 
      "macrophages", 
      "hydroxyurea", 
      "erythropoiesis", 
      "subgroups", 
      "total number", 
      "relevant correlations", 
      "monotherapy", 
      "remission", 
      "chemotherapy", 
      "pathomechanism", 
      "therapy", 
      "leukemia", 
      "myelo", 
      "CD61", 
      "diagnosis", 
      "blood", 
      "administration", 
      "quantitative differences", 
      "normoblasts", 
      "treatment", 
      "subpopulations", 
      "evaluation", 
      "megakaryocytes", 
      "examination", 
      "association", 
      "involvement", 
      "erythroblasts", 
      "megakaryopoiesis", 
      "fibroblasts", 
      "increase", 
      "conclusion", 
      "correlation", 
      "reduction", 
      "effect", 
      "cells", 
      "changes", 
      "findings", 
      "percentage", 
      "warrants", 
      "index", 
      "levels", 
      "data", 
      "differences", 
      "lineages", 
      "appropriate means", 
      "variables", 
      "study", 
      "features", 
      "number", 
      "nucleus", 
      "specimens", 
      "regeneration", 
      "contrast", 
      "corresponding indices", 
      "functional relationship", 
      "turnover", 
      "heterogeneity", 
      "bei", 
      "stage", 
      "similar way", 
      "frequency", 
      "patterns", 
      "corresponding variables", 
      "lines", 
      "relationship", 
      "classification", 
      "precursors", 
      "fibers", 
      "ratio", 
      "time", 
      "elaborate insight", 
      "means", 
      "amount", 
      "insights", 
      "size", 
      "synthesis", 
      "system", 
      "degradation", 
      "processing", 
      "density", 
      "process", 
      "way", 
      "properties", 
      "transition", 
      "dynamics", 
      "set", 
      "corresponding set"
    ], 
    "name": "Histologische und h\u00e4matologische Befunde bei der CML", 
    "pagination": "39-54", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1004984507"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002920050005"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10663668"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002920050005", 
      "https://app.dimensions.ai/details/publication/pub.1004984507"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_327.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002920050005"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002920050005'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002920050005'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002920050005'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002920050005'


 

This table displays all metadata directly associated to this object as RDF triples.

274 TRIPLES      20 PREDICATES      179 URIs      171 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002920050005 schema:about N0603b598825148b3bc2aa13b83e9c0bd
2 N158a45a088714ff698a1d899e32273d4
3 N15b61987427e4366aee38577eae6b8de
4 N41956103ded845d4990fc679d33c6ad7
5 N6735eb368df44749a804ec6e7cf1440f
6 N9c83caf2d7f948e284e3bcc530421df1
7 Na04f6e1bf89f47b6811a49e7a2cb263a
8 Na8038ba7b4fa42c39acd240b7cfcb8b9
9 Nc9cbee27ec6b4a04af560a1d3ffb3736
10 Ncac5d66be25c4a1fa759870bd8b9f25f
11 Nf348d4a93d654ce28416957bd7928bdd
12 Nfe738b97a10e445fa7ce1251cd4c2496
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author N3e0d0605d90646769184da658ed0c037
16 schema:datePublished 2000-01
17 schema:datePublishedReg 2000-01-01
18 schema:description An immunohistochemical and morphometric study was performed on bone marrow biopsies in 604 patients with chronic myelogenous leukemia (CML) to compare morphological and clinical features and to evaluate effects of interferon (IFN) and chemotherapy. Following morphometry significant correlations were calculated between number of CD61+ megakaryocytes, including their precursors with fiber density. This finding is in line with the close functional relationship between megakaryopoiesis and fibroblasts regarding the complex pathomechanism of myelofibrosis. The latter was observed in about 28% of patients already at diagnosis. In a similar way, the frequency of CD68+ macrophages was correlated with the amount of Ret40f+ nucleated erythroid precursors, implicating an involvement of this cell lineage in iron turnover, hemoglobin synthesis, and degradation of the expelled nuclei from normoblasts. The (α-D-galactosyl residue-expressing) Pseudo-Gaucher cells were detectable in 30% of pretreatment specimens. Moreover, significant associations were calculable between reduction in erythropoiesis or increase in fibers with clinical features such as hemoglobin level, percentages of myelo- and erythroblasts in the peripheral blood, and spleen size. These variables are in keeping with more advanced stages of CML. Based on our morphometric evaluations, a classification into three different histological subgroups: granulocytic, megakaryocytic, and myelofibrotic was carried out. This simplified staging system was correlated with corresponding sets of hematological data. Sequential biopsies in 173 patients with monotherapy by IFN, hydroxyurea (HU), or busulfan (BU) revealed a fibrogenic effect of IFN in contrast to a fiber-reducing property of HU. The dynamics of myelofibrosis and changes of major cell lineages during treatment were readily demonstrable by calculating corresponding indices. These included the ratios between quantitative differences of corresponding variables at repeated examinations and time. Thus, in patients with complete hematological remission following IFN administration, regeneration of erythropoiesis was found to be accompanied by an increase in the total number of CD68+ macrophages, including activated subpopulations. Histological subgroups showed a transition from a (nonfibrotic) granulocytic and megakaryocyte pattern to the myelofibrotic subtype in about 40% of patients. This change was opposed to a numerical reduction in the myelofibrotic subtype which occurred in 17 patients (36%), but predominantly in those under HU therapy. In conclusion, the striking heterogeneity of bone marrow features in CML warrants a careful morphological evaluation of trephine biopsies and appropriate means of processing to achieve relevant correlations with clinical data and, thus, allows a more elaborate insight into the dynamics of the disease process.
19 schema:genre article
20 schema:isAccessibleForFree false
21 schema:isPartOf Nda61cdea511843caa4bce5fabf9a13d8
22 Nfb7328088a9e48e4bfe66adabf5dea99
23 sg:journal.1446220
24 schema:keywords CD61
25 CD68
26 HU therapy
27 IFN administration
28 administration
29 advanced stage
30 amount
31 appropriate means
32 association
33 bei
34 biopsy
35 blood
36 bone marrow biopsy
37 bone marrow features
38 busulfan
39 careful morphological evaluation
40 cell lineages
41 cells
42 changes
43 chemotherapy
44 chronic myelogenous leukemia
45 classification
46 clinical data
47 clinical features
48 close functional relationship
49 complete hematological remission
50 complex pathomechanism
51 conclusion
52 contrast
53 correlation
54 corresponding indices
55 corresponding set
56 corresponding variables
57 data
58 degradation
59 density
60 diagnosis
61 differences
62 different histological subgroups
63 disease process
64 dynamics
65 dynamics of myelofibrosis
66 effect
67 effect of interferon
68 elaborate insight
69 erythroblasts
70 erythroid precursors
71 erythropoiesis
72 evaluation
73 examination
74 features
75 fiber density
76 fibers
77 fibroblasts
78 fibrogenic effects
79 findings
80 frequency
81 frequency of CD68
82 functional relationship
83 hematological data
84 hematological remission
85 hemoglobin levels
86 hemoglobin synthesis
87 heterogeneity
88 histological subgroups
89 hydroxyurea
90 increase
91 index
92 insights
93 interferon
94 involvement
95 iron turnover
96 leukemia
97 levels
98 lineages
99 lines
100 macrophages
101 major cell lineages
102 marrow biopsy
103 marrow features
104 means
105 megakaryocytes
106 megakaryopoiesis
107 monotherapy
108 morphological evaluation
109 morphometric evaluation
110 morphometric study
111 myelo
112 myelofibrosis
113 myelogenous leukemia
114 normoblasts
115 nucleated erythroid precursors
116 nucleus
117 number
118 number of CD61
119 numerical reduction
120 pathomechanism
121 patients
122 patterns
123 percentage
124 peripheral blood
125 precursors
126 pretreatment specimens
127 process
128 processing
129 properties
130 pseudo-Gaucher cells
131 quantitative differences
132 ratio
133 reduction
134 regeneration
135 regeneration of erythropoiesis
136 relationship
137 relevant correlations
138 remission
139 sequential biopsies
140 set
141 significant association
142 significant correlation
143 similar way
144 size
145 specimens
146 spleen size
147 stage
148 staging system
149 study
150 subgroups
151 subpopulations
152 subtypes
153 synthesis
154 system
155 therapy
156 time
157 total number
158 transition
159 treatment
160 trephine biopsy
161 turnover
162 variables
163 warrants
164 way
165 schema:name Histologische und hämatologische Befunde bei der CML
166 schema:pagination 39-54
167 schema:productId Nb0d2d5fdf9a44d24a867b98919fc284f
168 Nc4011f1c7cba43e0b7c1d393a33a38f6
169 Nd9e342ad61b94806b684ffcd4e8c7d7a
170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004984507
171 https://doi.org/10.1007/s002920050005
172 schema:sdDatePublished 2022-11-24T20:49
173 schema:sdLicense https://scigraph.springernature.com/explorer/license/
174 schema:sdPublisher Ncad0c19ebfad4c319f3d5e2f3fc8f51c
175 schema:url https://doi.org/10.1007/s002920050005
176 sgo:license sg:explorer/license/
177 sgo:sdDataset articles
178 rdf:type schema:ScholarlyArticle
179 N0603b598825148b3bc2aa13b83e9c0bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Erythropoiesis
181 rdf:type schema:DefinedTerm
182 N07a96bfae8a74867a6f3b3c961a56532 rdf:first sg:person.01116304300.49
183 rdf:rest rdf:nil
184 N158a45a088714ff698a1d899e32273d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Retrospective Studies
186 rdf:type schema:DefinedTerm
187 N15b61987427e4366aee38577eae6b8de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Bone Marrow
189 rdf:type schema:DefinedTerm
190 N194f187ad8934574b6899b4c1754cbcd rdf:first sg:person.0657700770.48
191 rdf:rest N07a96bfae8a74867a6f3b3c961a56532
192 N3e0d0605d90646769184da658ed0c037 rdf:first sg:person.01160664600.08
193 rdf:rest N9efed0f1f226465fb3cc31decc521491
194 N41956103ded845d4990fc679d33c6ad7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Hematopoietic Stem Cells
196 rdf:type schema:DefinedTerm
197 N6735eb368df44749a804ec6e7cf1440f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Bone Marrow Cells
199 rdf:type schema:DefinedTerm
200 N9c83caf2d7f948e284e3bcc530421df1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Biopsy
202 rdf:type schema:DefinedTerm
203 N9efed0f1f226465fb3cc31decc521491 rdf:first sg:person.012401210064.05
204 rdf:rest N194f187ad8934574b6899b4c1754cbcd
205 Na04f6e1bf89f47b6811a49e7a2cb263a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Humans
207 rdf:type schema:DefinedTerm
208 Na8038ba7b4fa42c39acd240b7cfcb8b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Leukemia, Myelogenous, Chronic, BCR-ABL Positive
210 rdf:type schema:DefinedTerm
211 Nb0d2d5fdf9a44d24a867b98919fc284f schema:name dimensions_id
212 schema:value pub.1004984507
213 rdf:type schema:PropertyValue
214 Nc4011f1c7cba43e0b7c1d393a33a38f6 schema:name doi
215 schema:value 10.1007/s002920050005
216 rdf:type schema:PropertyValue
217 Nc9cbee27ec6b4a04af560a1d3ffb3736 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Reference Values
219 rdf:type schema:DefinedTerm
220 Ncac5d66be25c4a1fa759870bd8b9f25f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Blood Cell Count
222 rdf:type schema:DefinedTerm
223 Ncad0c19ebfad4c319f3d5e2f3fc8f51c schema:name Springer Nature - SN SciGraph project
224 rdf:type schema:Organization
225 Nd9e342ad61b94806b684ffcd4e8c7d7a schema:name pubmed_id
226 schema:value 10663668
227 rdf:type schema:PropertyValue
228 Nda61cdea511843caa4bce5fabf9a13d8 schema:issueNumber 1
229 rdf:type schema:PublicationIssue
230 Nf348d4a93d654ce28416957bd7928bdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
231 schema:name Immunohistochemistry
232 rdf:type schema:DefinedTerm
233 Nfb7328088a9e48e4bfe66adabf5dea99 schema:volumeNumber 21
234 rdf:type schema:PublicationVolume
235 Nfe738b97a10e445fa7ce1251cd4c2496 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
236 schema:name Macrophages
237 rdf:type schema:DefinedTerm
238 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
239 schema:name Medical and Health Sciences
240 rdf:type schema:DefinedTerm
241 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
242 schema:name Clinical Sciences
243 rdf:type schema:DefinedTerm
244 sg:journal.1446220 schema:issn 2731-7188
245 2731-7196
246 schema:name Die Pathologie
247 schema:publisher Springer Nature
248 rdf:type schema:Periodical
249 sg:person.01116304300.49 schema:affiliation grid-institutes:None
250 schema:familyName Schaefer
251 schema:givenName H. E.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116304300.49
253 rdf:type schema:Person
254 sg:person.01160664600.08 schema:affiliation grid-institutes:grid.6190.e
255 schema:familyName Thiele
256 schema:givenName J.
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160664600.08
258 rdf:type schema:Person
259 sg:person.012401210064.05 schema:affiliation grid-institutes:grid.6190.e
260 schema:familyName Kvasnicka
261 schema:givenName H. M.
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012401210064.05
263 rdf:type schema:Person
264 sg:person.0657700770.48 schema:affiliation grid-institutes:None
265 schema:familyName Schmitt-Graeff
266 schema:givenName A.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657700770.48
268 rdf:type schema:Person
269 grid-institutes:None schema:alternateName Pathologisches Institut der Albert-Ludwigs-Universität Freiburg, DE
270 schema:name Pathologisches Institut der Albert-Ludwigs-Universität Freiburg, DE
271 rdf:type schema:Organization
272 grid-institutes:grid.6190.e schema:alternateName Zentrum für Pathologie der Universität zu Köln, DE
273 schema:name Zentrum für Pathologie der Universität zu Köln, DE
274 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...